Haemonetics Corp

NYSE: HAE
$87.42
+$0.89 (+1.0%)
Closing Price on November 8, 2024

HAE Stock Chart and Intraday Price

HAE Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 125 SUMMER STREET, BOSTON, MA, US
Fiscal Year End March
Latest Quarter 12/31/2023
Market Cap 3,766.30M USD
Shares Outstanding 50,786,000
Haemonetics Corp is a global healthcare company specializing in innovative blood management solutions. It offers a wide range of products, including automated plasma collection systems, blood component and manual whole blood collection systems, and advanced software for managing donor information and blood supplies. Additionally, Haemonetics provides hospital products like hemostasis analyzer systems for assessing patient hemostasis and autologous blood recovery systems used in various surgeries. With a focus on improving patient care and safety, the company serves healthcare providers through a combination of direct sales and distributors. Founded in 1971, Haemonetics is headquartered in Boston, Massachusetts.

HAE Articles

Wednesday's top analyst upgrades and downgrades included Ally Financial, Applied Materials, CrowdStrike, Fidelity National Information Services, First Solar, Fortinet, Newmont, Occidental Petroleum,...
Tuesday's top analyst upgrades and downgrades included Canopy Growth, Constellation Brands, Equifax, FedEx, Franklin Resources, Micron Technology, Paramount Global, RH and T-Mobile.
These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate some significant portfolio alpha.